Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III
M. Ronderos et al., Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III, J CLIN PER, 27(10), 2000, pp. 778-786
The objectives of this study were to evaluate the possible association of p
eriodontal disease with (1) femoral bone mineral density (BMD), and (2) est
rogen replacement therapy in a large sample of US adults (N=11,655), The me
an clinical attachment loss (CAL) per person was the main outcome variable.
Based on the total BMD of the proximal femur and using the WHO diagnostic
criteria, subjects were classified as having osteoporosis, osteopenia, or n
ormal BMD. After adjusting for confounders, females with high calculus scor
es and low BMD had significantly more CAL than females with normal BMD and
similar calculus scores (p<0.0001), No association was observed among women
with low and intermediate levels of calculus. The greater CAL present amon
g women with low BMD was associated with gingival recession. Patterns of fi
ndings were similar but equivocal among men, of whom only 66 were osteoporo
tic. After adjustment for possible confounders, postmenopausal women who re
ported having used estrogen replacement therapy presented significantly les
s mean CAL than those who never used estrogen. These findings indicate that
in the presence of high calculus scores, females with osteoporosis are at
increased risk for attachment loss and that this risk may be attenuated by
the use of estrogen replacement therapy.